Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kwee Yong

Showing results (21-30 of 187) with videos related to

Pageof 19
Sort By:
The Lancet. Haematology|May 28, 2021
CAR T-cell therapy for multiple myeloma: state of the art and prospectsNiels W C J van de Donk, Saad Z Usmani, Kwee Yong
Hematological Oncology|September 3, 2013
Myeloma presenting during pregnancyDean Smith, Jane Stevens, John Quinn, et al.
Leukemia & Lymphoma|September 17, 2013
Plasma cell neoplasm associated chronic neutrophilic leukemia with membrane proximal and truncating CSF3R mutationsPiers Blombery, Jaimal Kothari, Kwee Yong, et al.
British Journal of Haematology|December 10, 2009
CD20-positive multiple myeloma - differential expression of cyclins D1 and D2 suggests a heterogeneous diseaseJohn Quinn, Laura Percy, Janet Glassford, et al.
British Journal of Haematology|May 27, 2015
Global hypomethylation in myeloma is associated with poor prognosisJonathan I Sive, Andrew Feber, Dean Smith, et al.
Ejhaem|July 18, 2022
A rare case of relapsed multiple myeloma with aberrant T-cell antigen expression and skin plasmacytomasCatherine S Y Lecat, Manuel Rodriguez-Justo, Dominic Patel, et al.
British Journal of Haematology|April 23, 2015
Cohort analysis of FISH testing of CD138(+) cells in relapsed multiple myeloma: implications for prognosis and choice of therapyDean Smith, Clemency Stephenson, Laura Percy, et al.
British Journal of Haematology|April 11, 2016
Real world experience of bortezomib re-treatment for patients with multiple myeloma at first relapseYasmin Reyal, Rakesh Popat, Simon Cheesman, et al.
BMJ Open|November 29, 2015
Multiple myeloma and physical activity: a scoping reviewLee Smith, Orla McCourt, Malgorzata Henrich, et al.
Blood|August 17, 2010
APRIL promotes cell-cycle progression in primary multiple myeloma cells: influence of D-type cyclin group and translocation statusJohn Quinn, Janet Glassford, Laura Percy, et al.
Pageof 19

Showing results (21-30 of 187) with videos related to

Sort By:
Pageof 19
The Lancet. Haematology|May 28, 2021
CAR T-cell therapy for multiple myeloma: state of the art and prospectsNiels W C J van de Donk, Saad Z Usmani, Kwee Yong
Hematological Oncology|September 3, 2013
Myeloma presenting during pregnancyDean Smith, Jane Stevens, John Quinn, et al.
Leukemia & Lymphoma|September 17, 2013
Plasma cell neoplasm associated chronic neutrophilic leukemia with membrane proximal and truncating CSF3R mutationsPiers Blombery, Jaimal Kothari, Kwee Yong, et al.
British Journal of Haematology|December 10, 2009
CD20-positive multiple myeloma - differential expression of cyclins D1 and D2 suggests a heterogeneous diseaseJohn Quinn, Laura Percy, Janet Glassford, et al.
British Journal of Haematology|May 27, 2015
Global hypomethylation in myeloma is associated with poor prognosisJonathan I Sive, Andrew Feber, Dean Smith, et al.
Ejhaem|July 18, 2022
A rare case of relapsed multiple myeloma with aberrant T-cell antigen expression and skin plasmacytomasCatherine S Y Lecat, Manuel Rodriguez-Justo, Dominic Patel, et al.
British Journal of Haematology|April 23, 2015
Cohort analysis of FISH testing of CD138(+) cells in relapsed multiple myeloma: implications for prognosis and choice of therapyDean Smith, Clemency Stephenson, Laura Percy, et al.
British Journal of Haematology|April 11, 2016
Real world experience of bortezomib re-treatment for patients with multiple myeloma at first relapseYasmin Reyal, Rakesh Popat, Simon Cheesman, et al.
BMJ Open|November 29, 2015
Multiple myeloma and physical activity: a scoping reviewLee Smith, Orla McCourt, Malgorzata Henrich, et al.
Blood|August 17, 2010
APRIL promotes cell-cycle progression in primary multiple myeloma cells: influence of D-type cyclin group and translocation statusJohn Quinn, Janet Glassford, Laura Percy, et al.
Pageof 19